ACESO Clinical Study on Esophageal Disorders

The document is a report detailing the ACESO clinical study, which focuses on innovative treatments for esophageal disorders, including eosinophilic esophagitis and esophageal cancer. It outlines the collaboration between pharmaceutical research, medical technology, and mechanical engineering to develop a unique administration system for delivering medication directly to the esophagus. The study describes the technology behind a hard gelatin capsule containing a thin film with an active ingredient that adheres to the esophageal mucosa, allowing for targeted and sustained treatment. Initial phases of clinical development have shown promising results, confirming the efficacy of the treatment compared to a placebo. The report also discusses future plans for regulatory discussions to initiate further studies aimed at obtaining approval for broader use. The collaboration between Fette Compacting and EsoCap is highlighted as a significant factor in the study's success, emphasizing the importance of partnerships in advancing healthcare solutions.